Oncogenic Ras Isoforms Signaling Specificity at the Membrane

Zhou, 2016, The role of wild type RAS isoforms in cancer, Semin Cell Dev Biol, 58, 60, 10.1016/j.semcdb.2016.07.012

Zhang, 2016, The renewed battle against RAS-mutant cancers, Cell Mol Life Sci, 73, 1845, 10.1007/s00018-016-2155-8

Nussinov, 2016, Oncogenic KRAS signaling and YAP1/beta-catenin: similar cell cycle control in tumor initiation, Semin Cell Dev Biol, 58, 79, 10.1016/j.semcdb.2016.04.001

Hobbs, 2016, RAS isoforms and mutations in cancer at a glance, J Cell Sci, 129, 1287, 10.1242/jcs.182873

Nakhaeizadeh, 2016, The RAS-effector interface: isoform-specific differences in the effector binding regions, PLoS One, 11, e0167145, 10.1371/journal.pone.0167145

Castellano, 2011, Functional specificity of Ras isoforms: so similar but so different, Genes Cancer, 2, 216, 10.1177/1947601911408081

Newlaczyl, 2017, Quantification of spatiotemporal patterns of Ras isoform expression during development, Sci Rep, 7, 41297, 10.1038/srep41297

Parker, 2015, The Ras–membrane interface: isoform-specific differences in the catalytic domain, Mol Cancer Res, 13, 595, 10.1158/1541-7786.MCR-14-0535

Prior, 2012, A comprehensive survey of Ras mutations in cancer, Cancer Res, 72, 2457, 10.1158/0008-5472.CAN-11-2612

Voice, 1999, Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility, J Biol Chem, 274, 17164, 10.1074/jbc.274.24.17164

Patek, 2008, Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis, Exp Cell Res, 314, 1105, 10.1016/j.yexcr.2007.11.004

Abubaker, 2009, Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma, J Pathol, 219, 435, 10.1002/path.2625

Tsai, 2015, K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif, Proc Natl Acad Sci U S A, 112, 779, 10.1073/pnas.1412811112

Li, 2017, Computational modeling reveals that signaling lipids modulate the orientation of K-Ras4A at the membrane reflecting protein topology, Structure, 25, 679, 10.1016/j.str.2017.02.007

Nussinov, 2016, A new view of Ras isoforms in cancers, Cancer Res, 76, 18, 10.1158/0008-5472.CAN-15-1536

Schmick, 2014, KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport, Cell, 157, 459, 10.1016/j.cell.2014.02.051

Zhou, 2017, Lipid-sorting specificity encoded in K-Ras membrane anchor regulates signal output, Cell, 168, 239, 10.1016/j.cell.2016.11.059

Blazevits, 2016, Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering, Sci Rep, 6, 24165, 10.1038/srep24165

Najumudeen, 2015, Phenotypic screening identifies protein synthesis inhibitors as H-Ras-Nanocluster-Increasing tumor growth inducers, Biochemistry, 54, 7212, 10.1021/acs.biochem.5b00724

Zhou, 2015, SIGNAL TRANSDUCTION. Membrane potential modulates plasma membrane phospholipid dynamics and K-Ras signaling, Science, 349, 873, 10.1126/science.aaa5619

Zhou, 2015, Ras nanoclusters: versatile lipid-based signaling platforms, Biochim Biophys Acta, 1853, 841, 10.1016/j.bbamcr.2014.09.008

Zhou, 2014, RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling, Oncol Rep, 32, 1505, 10.3892/or.2014.3387

Rauch, 2017, Spatial regulation of ARAF controls the MST2-Hippo pathway, Small GTPases, 10.1080/21541248.2017.1288686

Lu, 2016, Ras conformational ensembles, allostery, and signaling, Chem Rev, 116, 6607, 10.1021/acs.chemrev.5b00542

Pylayeva-Gupta, 2011, RAS oncogenes: weaving a tumorigenic web, Nat Rev Cancer, 11, 761, 10.1038/nrc3106

Nussinov, 2017, Intrinsic protein disorder in oncogenic KRAS signaling, Cell Mol Life Sci, 74, 3245, 10.1007/s00018-017-2564-3

Baietti, 2016, OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination, EMBO Mol Med, 8, 288, 10.15252/emmm.201505972

Simons, 2004, Model systems, lipid rafts, and cell membranes, Annu Rev Biophys Biomol Struct, 33, 269, 10.1146/annurev.biophys.32.110601.141803

Fujiwara, 2002, Phospholipids undergo hop diffusion in compartmentalized cell membrane, J Cell Biol, 157, 1071, 10.1083/jcb.200202050

Murase, 2004, Ultrafine membrane compartments for molecular diffusion as revealed by single molecule techniques, Biophys J, 86, 4075, 10.1529/biophysj.103.035717

Ahearn, 2011, Regulating the regulator: post-translational modification of RAS, Nat Rev Mol Cell Biol, 13, 39, 10.1038/nrm3255

Bandaru, 2017, Deconstruction of the Ras switching cycle through saturation mutagenesis, Elife, 6, 10.7554/eLife.27810

Banerjee, 2016, The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding, Curr Opin Struct Biol, 36, 10, 10.1016/j.sbi.2015.11.010

Erwin, 2017, Influence of isoform-specific Ras lipidation motifs on protein partitioning and dynamics in model membrane systems of various complexity, Biol Chem, 398, 547, 10.1515/hsz-2016-0289

Fetics, 2015, Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD, Structure, 23, 505, 10.1016/j.str.2014.12.017

Ting, 2015, Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding, FASEB J, 29, 3750, 10.1096/fj.15-271510

Prakash, 2016, Oncogenic K-Ras binds to an anionic membrane in two distinct orientations: a molecular dynamics analysis, Biophys J, 110, 1125, 10.1016/j.bpj.2016.01.019

Yin, 2017, A KRAS GTPase K104Q mutant retains downstream signaling by offsetting defects in regulation, J Biol Chem, 292, 4446, 10.1074/jbc.M116.762435

Solman, 2015, Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation, Elife, 4, e08905, 10.7554/eLife.08905

Mazhab-Jafari, 2015, Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site, Proc Natl Acad Sci U S A, 112, 6625, 10.1073/pnas.1419895112

Westcott, 2015, The mutational landscapes of genetic and chemical models of Kras-driven lung cancer, Nature, 517, 489, 10.1038/nature13898

Smithson, 2016, Contextual signaling in cancer, Semin Cell Dev Biol, 58, 118, 10.1016/j.semcdb.2016.06.002

Kanehisa, 2017, KEGG: new perspectives on genomes, pathways, diseases and drugs, Nucleic Acids Res, 45, D353, 10.1093/nar/gkw1092

Frauenfelder, 1991, The energy landscapes and motions of proteins, Science, 254, 1598, 10.1126/science.1749933

Lu, 2016, The structural basis of oncogenic mutations G12, G13 and Q61 in small GTPase K-Ras4B, Sci Rep, 6, 21949, 10.1038/srep21949

Buhrman, 2010, Allosteric modulation of Ras positions Q61 for a direct role in catalysis, Proc Natl Acad Sci U S A, 107, 4931, 10.1073/pnas.0912226107

Resh, 2013, Covalent lipid modifications of proteins, Curr Biol, 23, R431, 10.1016/j.cub.2013.04.024

Resh, 2006, Trafficking and signaling by fatty-acylated and prenylated proteins, Nat Chem Biol, 2, 584, 10.1038/nchembio834

Jacobson, 2007, Lipid rafts: at a crossroad between cell biology and physics, Nat Cell Biol, 9, 7, 10.1038/ncb0107-7

Kapoor, 2012, The role of G-domain orientation and nucleotide state on the Ras isoform-specific membrane interaction, Eur Biophys J, 41, 801, 10.1007/s00249-012-0841-5

Lingwood, 2009, Lipid rafts as functional heterogeneity in cell membranes, Biochem Soc Trans, 37, 955, 10.1042/BST0370955

Simons, 2000, Lipid rafts and signal transduction, Nat Rev Mol Cell Biol, 1, 31, 10.1038/35036052

Marlier, 2015, A mechanistic study of thioester hydrolysis with heavy atom kinetic isotope effects, J Org Chem, 80, 1905, 10.1021/jo502472m

Lane, 2006, Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I, J Lipid Res, 47, 681, 10.1194/jlr.R600002-JLR200

Khmelinskaia, 2014, Changes in membrane organization upon spontaneous insertion of 2-hydroxylated unsaturated fatty acids in the lipid bilayer, Langmuir, 30, 2117, 10.1021/la403977f

Jang, 2015, Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region, J Biol Chem, 290, 9465, 10.1074/jbc.M114.620724

Abankwa, 2010, Ras membrane orientation and nanodomain localization generate isoform diversity, Proc Natl Acad Sci U S A, 107, 1130, 10.1073/pnas.0903907107

Jang, 2016, The higher level of complexity of K-Ras4B activation at the membrane, FASEB J, 30, 1643, 10.1096/fj.15-279091

Sperlich, 2016, Regulation of K-Ras4B membrane binding by calmodulin, Biophys J, 111, 113, 10.1016/j.bpj.2016.05.042

Cho, 2016, AMPK and endothelial nitric oxide synthase signaling regulates K-Ras plasma membrane interactions via cyclic GMP-dependent protein kinase 2, Mol Cell Biol, 36, 3086, 10.1128/MCB.00365-16

Zhang, 2017, Phosphorylation weakens but does not inhibit membrane binding and clustering of K-Ras4B, ACS Chem Biol, 12, 1703, 10.1021/acschembio.7b00165

Eisenberg, 2013, The role of palmitoylation in regulating Ras localization and function, Biochem Soc Trans, 41, 79, 10.1042/BST20120268

Wang, 2016, Protein prenylation: unique fats make their mark on biology, Nat Rev Mol Cell Biol, 17, 110, 10.1038/nrm.2015.11

Chen, 2000, The C-terminal polylysine region and methylation of K-Ras are critical for the interaction between K-Ras and microtubules, J Biol Chem, 275, 41251, 10.1074/jbc.M006687200

Cox, 2015, Targeting RAS membrane association: back to the future for anti-RAS drug discovery?, Clin Cancer Res, 21, 1819, 10.1158/1078-0432.CCR-14-3214

Dharmaiah, 2016, Structural basis of recognition of farnesylated and methylated KRAS4b by PDEdelta, Proc Natl Acad Sci U S A, 113, E6766, 10.1073/pnas.1615316113

Muratcioglu, 2017, PDEδ binding to Ras isoforms provides a route to proper membrane localization, J Phys Chem B, 121, 5917, 10.1021/acs.jpcb.7b03035

Chavan, 2015, High-affinity interaction of the K-Ras4B hypervariable region with the Ras active site, Biophys J, 109, 2602, 10.1016/j.bpj.2015.09.034

van Keulen, 2017, Effect of N-terminal myristoylation on the active conformation of galphai1-GTP, Biochemistry, 56, 271, 10.1021/acs.biochem.6b00388

Patra, 2016, Translational dynamics of lipidated Ras proteins in the presence of crowding agents and compatible osmolytes, Chemphyschem, 17, 2164, 10.1002/cphc.201600179

Lu, 2015, GTP binding and oncogenic mutations may attenuate hypervariable region (HVR)-catalytic domain interactions in small GTPase K-Ras4B, exposing the effector binding site, J Biol Chem, 290, 28887, 10.1074/jbc.M115.664755

Jang, 2016, Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers, Biochem J, 473, 1719, 10.1042/BCJ20160031

Abankwa, 2008, A novel switch region regulates H-ras membrane orientation and signal output, EMBO J, 27, 727, 10.1038/emboj.2008.10

Sunshine, 2017, Membrane lipids and cell signaling, Curr Opin Lipidol, 28, 408, 10.1097/MOL.0000000000000443

Goodwin, 2005, Ras diffusion is sensitive to plasma membrane viscosity, Biophys J, 89, 1398, 10.1529/biophysj.104.055640

Kenworthy, 2004, Dynamics of putative raft-associated proteins at the cell surface, J Cell Biol, 165, 735, 10.1083/jcb.200312170

Niv, 2002, Activated K-Ras and H-Ras display different interactions with saturable nonraft sites at the surface of live cells, J Cell Biol, 157, 865, 10.1083/jcb.200202009

Liao, 2016, RASSF5: an MST activator and tumor suppressor in vivo but opposite in vitro, Curr Opin Struct Biol, 41, 217, 10.1016/j.sbi.2016.09.001

Prior, 2003, Direct visualization of Ras proteins in spatially distinct cell surface microdomains, J Cell Biol, 160, 165, 10.1083/jcb.200209091

Plowman, 2005, Ras signaling from plasma membrane and endomembrane microdomains, Biochim Biophys Acta, 1746, 274, 10.1016/j.bbamcr.2005.06.004

Posada, 2016, ASPP2 is a novel Pan-Ras nanocluster scaffold, PLoS One, 11, e0159677, 10.1371/journal.pone.0159677

Choi, 2016, Agonist-stimulated phosphatidylinositol-3,4,5-trisphosphate generation by scaffolded phosphoinositide kinases, Nat Cell Biol, 18, 1324, 10.1038/ncb3441

LeCour, 2016, The structural basis for Cdc42-induced dimerization of IQGAPs, Structure, 24, 1499, 10.1016/j.str.2016.06.016

Jambrina, 2016, Phosphorylation of RAF kinase dimers drives conformational changes that facilitate transactivation, Angew Chem Int Ed Engl, 55, 983, 10.1002/anie.201509272

Donninger, 2016, Ras signaling through RASSF proteins, Semin Cell Dev Biol, 58, 86, 10.1016/j.semcdb.2016.06.007

Sanchez-Sanz, 2016, SARAH domain-mediated MST2-RASSF dimeric interactions, PLoS Comput Biol, 12, e1005051, 10.1371/journal.pcbi.1005051

Posada, 2017, Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner, Oncotarget, 8, 44550, 10.18632/oncotarget.17819

Murakoshi, 2004, Single-molecule imaging analysis of Ras activation in living cells, Proc Natl Acad Sci U S A, 101, 7317, 10.1073/pnas.0401354101

Hibino, 2003, Single- and multiple-molecule dynamics of the signaling from H-Ras to cRaf-1 visualized on the plasma membrane of living cells, Chemphyschem, 4, 748, 10.1002/cphc.200300731

Rajakulendran, 2009, A dimerization-dependent mechanism drives RAF catalytic activation, Nature, 461, 542, 10.1038/nature08314

Spencer-Smith, 2017, Inhibition of RAS function through targeting an allosteric regulatory site, Nat Chem Biol, 13, 62, 10.1038/nchembio.2231

Nussinov, 2017, Calmodulin and PI3K signaling in KRAS cancers, Trends Cancer, 3, 214, 10.1016/j.trecan.2017.01.007

Michael, 2016, Regulation of H-Ras-driven MAPK signaling, transformation and tumorigenesis, but not PI3K signaling and tumor progression, by plasma membrane microdomains, Oncogenesis, 5, e228, 10.1038/oncsis.2016.36

Cho, 2015, Inhibition of acid sphingomyelinase depletes cellular phosphatidylserine and mislocalizes K-Ras from the plasma membrane, Mol Cell Biol, 36, 363, 10.1128/MCB.00719-15

Gregory, 2017, Interaction of KRas4b with anionic membranes: a special role for PIP2, Biochem Biophys Res Commun, 487, 351, 10.1016/j.bbrc.2017.04.063

Wolfman, 2001, Ras isoform-specific signaling: location, location, location, Sci STKE, 2001, pe2, 10.1126/stke.2001.96.pe2

Goldfinger, 2017, Regulation of Ras signaling and function by plasma membrane microdomains, Biosci Trends, 11, 23, 10.5582/bst.2016.01220

Novotny, 2017, Farnesyltransferase-mediated delivery of a covalent inhibitor overcomes alternative prenylation to mislocalize K-Ras, ACS Chem Biol, 12, 1956, 10.1021/acschembio.7b00374

Hancock, 2005, Ras plasma membrane signalling platforms, Biochem J, 389, 1, 10.1042/BJ20050231

Matallanas, 2003, Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization, J Biol Chem, 278, 4572, 10.1074/jbc.M209807200

Eisenberg, 2011, Raft protein clustering alters N-Ras membrane interactions and activation pattern, Mol Cell Biol, 31, 3938, 10.1128/MCB.05570-11

Gentry, 2015, Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases, J Biol Chem, 290, 22851, 10.1074/jbc.M115.656710

Nakhaei-Rad, 2015, The function of embryonic stem cell-expressed RAS (E-RAS), a unique RAS family member, correlates with its additional motifs and its structural properties, J Biol Chem, 290, 15892, 10.1074/jbc.M115.640607

Nicolini, 2006, Visualizing association of N-ras in lipid microdomains: influence of domain structure and interfacial adsorption, J Am Chem Soc, 128, 192, 10.1021/ja055779x

Astorgues-Xerri, 2014, Unraveling galectin-1 as a novel therapeutic target for cancer, Cancer Treat Rev, 40, 307, 10.1016/j.ctrv.2013.07.007

Elad-Sfadia, 2004, Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity, J Biol Chem, 279, 34922, 10.1074/jbc.M312697200

Shalom-Feuerstein, 2008, Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras, Biochim Biophys Acta, 1783, 985, 10.1016/j.bbamcr.2008.03.009

Belanis, 2008, Galectin-1 is a novel structural component and a major regulator of h-ras nanoclusters, Mol Biol Cell, 19, 1404, 10.1091/mbc.e07-10-1053

Silvius, 2005, Partitioning of membrane molecules between raft and non-raft domains: insights from model-membrane studies, Biochim Biophys Acta, 1746, 193, 10.1016/j.bbamcr.2005.09.003

Janosi, 2012, Organization, dynamics, and segregation of Ras nanoclusters in membrane domains, Proc Natl Acad Sci U S A, 109, 8097, 10.1073/pnas.1200773109

Wang, 2015, K-Ras promotes tumorigenicity through suppression of non-canonical Wnt signaling, Cell, 163, 1237, 10.1016/j.cell.2015.10.041

Nussinov, 2015, The key role of calmodulin in KRAS-driven adenocarcinomas, Mol Cancer Res, 13, 1265, 10.1158/1541-7786.MCR-15-0165

Weise, 2012, Dissociation of the K-Ras4B/PDEdelta complex upon contact with lipid membranes: membrane delivery instead of extraction, J Am Chem Soc, 134, 11503, 10.1021/ja305518h

Berchtold, 2014, The many faces of calmodulin in cell proliferation, programmed cell death, autophagy, and cancer, Biochim Biophys Acta, 1843, 398, 10.1016/j.bbamcr.2013.10.021

Anguita, 2017, Src-family tyrosine kinases and the Ca2+ signal, Biochim Biophys Acta, 1864, 915, 10.1016/j.bbamcr.2016.10.022

Jang, 2017, Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction, J Biol Chem, 292, 12544, 10.1074/jbc.M117.785063

Joyal, 1997, Calmodulin activates phosphatidylinositol 3-kinase, J Biol Chem, 272, 28183, 10.1074/jbc.272.45.28183

Chaudhuri, 2016, Membrane translocation of TRPC6 channels and endothelial migration are regulated by calmodulin and PI3 kinase activation, Proc Natl Acad Sci U S A, 113, 2110, 10.1073/pnas.1600371113

Siempelkamp, 2017, Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas, J Biol Chem, 292, 12256, 10.1074/jbc.M117.789263

Liao, 2003, K-ras regulates the steady-state expression of matrix metalloproteinase 2 in fibroblasts, J Biol Chem, 278, 31871, 10.1074/jbc.M301931200

Liao, 2006, Growth factor-dependent AKT activation and cell migration requires the function of c-K(B)-Ras versus other cellular ras isoforms, J Biol Chem, 281, 29730, 10.1074/jbc.M600668200

Zhang, 2017, Phosphorylated, Biophys J, 113, 1956, 10.1016/j.bpj.2017.09.008

Nussinov, 2017, A new view of pathway-driven drug resistance in tumor proliferation, Trends Pharmacol Sci, 38, 427, 10.1016/j.tips.2017.02.001

Vadas, 2011, Structural basis for activation and inhibition of class I phosphoinositide 3-kinases, Sci Signal, 4, re2, 10.1126/scisignal.2002165

Echeverria, 2015, Oncogenic mutations weaken the interactions that stabilize the p110alpha-p85alpha heterodimer in phosphatidylinositol 3-kinase alpha, FEBS J, 282, 3528, 10.1111/febs.13365

Geering, 2007, Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers, Proc Natl Acad Sci U S A, 104, 7809, 10.1073/pnas.0700373104

Nan, 2015, Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway, Proc Natl Acad Sci U S A, 112, 7996, 10.1073/pnas.1509123112

Muratcioglu, 2015, GTP-dependent K-Ras dimerization, Structure, 23, 1325, 10.1016/j.str.2015.04.019

Cho, 2012, Raf inhibitors target ras spatiotemporal dynamics, Curr Biol, 22, 945, 10.1016/j.cub.2012.03.067

Sarkar-Banerjee, 2017, Spatiotemporal analysis of K-Ras plasma membrane interactions reveals multiple high order homo-oligomeric complexes, J Am Chem Soc, 139, 13466, 10.1021/jacs.7b06292

Guzman, 2014, The efficacy of Raf kinase recruitment to the GTPase H-ras depends on H-ras membrane conformer-specific nanoclustering, J Biol Chem, 289, 9519, 10.1074/jbc.M113.537001

Miller, 2014, Structural basis of nSH2 regulation and lipid binding in PI3Kalpha, Oncotarget, 5, 5198, 10.18632/oncotarget.2263

Villalonga, 2001, Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling, Mol Cell Biol, 21, 7345, 10.1128/MCB.21.21.7345-7354.2001

Lopez-Alcala, 2008, Identification of essential interacting elements in K-Ras/calmodulin binding and its role in K-Ras localization, J Biol Chem, 283, 10621, 10.1074/jbc.M706238200

Fivaz, 2005, Reversible intracellular translocation of KRas but not HRas in hippocampal neurons regulated by Ca2+/calmodulin, J Cell Biol, 170, 429, 10.1083/jcb.200409157

Chavan, 2015, Plasma membrane regulates Ras signaling networks, Cell Logist, 5, e1136374, 10.1080/21592799.2015.1136374

Siljamaki, 2016, SPRED1 interferes with K-ras but not H-ras membrane anchorage and signaling, Mol Cell Biol, 36, 2612, 10.1128/MCB.00191-16

Bender, 2015, Activated k-ras, but not h-ras or N-ras, regulates brain neural stem cell proliferation in a raf/rb-dependent manner, Stem Cells, 33, 1998, 10.1002/stem.1990

Macrae, 2005, A conditional feedback loop regulates Ras activity through EphA2, Cancer Cell, 8, 111, 10.1016/j.ccr.2005.07.005

Young, 2013, Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling, Cancer Discov, 3, 112, 10.1158/2159-8290.CD-12-0231

Burgess, 2017, KRAS allelic imbalance enhances fitness and modulates MAP kinase dependence in cancer, Cell, 168, 817, 10.1016/j.cell.2017.01.020

Matallanas, 2011, Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras, Mol Cell, 44, 893, 10.1016/j.molcel.2011.10.016

Doherty, 2017, KRAS allelic imbalance: strengths and weaknesses in numbers, Trends Mol Med, 23, 377, 10.1016/j.molmed.2017.03.005

Mao, 2016, Microsecond timescale dynamics of GDP-bound Ras underlies the formation of novel inhibitor-binding pockets, Angew Chem Int Ed Engl, 55, 15629, 10.1002/anie.201608653

Lu, 2016, Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view, Chem Soc Rev, 45, 4929, 10.1039/C5CS00911A

Rauch, 2016, Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation, Cell Death Differ, 23, 1283, 10.1038/cdd.2016.2

Choi, 2017, And Akt-ion! IQGAP1 in control of signaling pathways, EMBO J, 36, 967, 10.15252/embj.201796827

Nussinov, 2016, K-Ras4B/calmodulin/PI3Kα: a promising new adenocarcinoma-specific drug target?, Expert Opin Ther Targets, 20, 831, 10.1517/14728222.2016.1135131

Lin, 2017, Targeting the Ras palmitoylation/depalmitoylation cycle in cancer, Biochem Soc Trans, 45, 913, 10.1042/BST20160303

Shih, 2017, A novel galectin-1 inhibitor discovered through one-bead two-compound library potentiates the antitumor effects of paclitaxel in vivo, Mol Cancer Ther, 16, 1212, 10.1158/1535-7163.MCT-16-0690

Michael, 2016, Inhibition of galectin-1 sensitizes HRAS-driven tumor growth to rapamycin treatment, Anticancer Res, 36, 5053, 10.21873/anticanres.11074

Spencer-Smith, 2017, Targeting the alpha4-alpha5 interface of RAS results in multiple levels of inhibition, Small GTPases

Papke, 2016, Identification of pyrazolopyridazinones as PDEdelta inhibitors, Nat Commun, 7, 11360, 10.1038/ncomms11360

Nussinov, 2013, ‘Pathway drug cocktail’: targeting Ras signaling based on structural pathways, Trends Mol Med, 19, 695, 10.1016/j.molmed.2013.07.009

Tong, 2017, Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer, Cancer Lett, 405, 100, 10.1016/j.canlet.2017.07.023

Guri, 2016, mTOR signaling confers resistance to targeted cancer drugs, Trends Cancer, 2, 688, 10.1016/j.trecan.2016.10.006